| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.254 | 17.494 | 13.025 | 22.868 | 30.292 | 23.351 | 37.925 | 28.008 | 51.868 | 54.591 |
| Total Income - EUR | 25.254 | 17.494 | 13.025 | 22.868 | 30.292 | 23.351 | 37.925 | 28.009 | 51.869 | 54.592 |
| Total Expenses - EUR | 16.107 | 13.376 | 12.898 | 16.933 | 17.348 | 19.554 | 34.185 | 44.243 | 51.606 | 68.330 |
| Gross Profit/Loss - EUR | 9.147 | 4.118 | 127 | 5.935 | 12.944 | 3.796 | 3.740 | -16.235 | 263 | -13.738 |
| Net Profit/Loss - EUR | 8.389 | 3.769 | -3 | 5.706 | 12.641 | 3.417 | 3.360 | -16.515 | -256 | -14.284 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Criobio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.470 | 674 | 280 | -170 | 0 | 0 | 0 | 0 | 2.969 | 2.199 |
| Current Assets | 15.740 | 22.817 | 16.964 | 23.154 | 35.994 | 41.431 | 18.368 | 13.277 | 18.186 | 13.895 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 158 | 0 | 0 | 0 | 0 |
| Receivables | 1.658 | 1.663 | 1.663 | 2.093 | 3.668 | 4.306 | 2.970 | 5.701 | 8.454 | 9.845 |
| Cash | 14.082 | 21.154 | 15.301 | 21.062 | 32.326 | 36.967 | 15.398 | 7.576 | 9.733 | 4.050 |
| Shareholders Funds | 6.168 | 9.874 | 9.704 | 15.232 | 27.623 | 6.579 | 9.793 | -7.908 | -8.139 | -22.378 |
| Social Capital | 1.496 | 1.481 | 1.456 | 1.429 | 1.401 | 1.375 | 1.344 | 1.348 | 1.344 | 1.337 |
| Debts | 12.041 | 13.617 | 7.540 | 7.752 | 8.371 | 34.852 | 8.575 | 21.185 | 29.295 | 38.473 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Criobio S.r.l.